Citius Pharmaceuticals Inc (CTXR) Stock: What the Analysts are Saying
The stock has a 36-month beta value of 1.51. Opinions on the stock are mixed, with 1 analysts rating it as a “buy”, 0 as “overweight”, 1 as “hold”, and 0 as “sell”. The public float for CTXR is 20.27M, and at present, short sellers hold a 13.42% of that float. On February 12, 2026, … Read more